Table 8.
Subjective improvement in pigmentation at 6 months follow-up, compared to baseline, based on patient feedback (Likert scale) and physician assessment (photographic analysis).
| Type of Dermal Pigmentation (Number of Patients) |
Improvement in Pigmentation at 6 Months Post-Therapy, Compared to Baseline | |||||
|---|---|---|---|---|---|---|
| Patient Feedback | Physician Assessment | |||||
| Likert Scale (0 to 10) |
Excellent (>90% Improvement; Score: 5) |
Good (75–90% Improvement; Score: 4) |
Moderate (50–74% Improvement; Score: 3) |
Mild (25–49% Improvement; Score: 2) |
None (<25% Improvement; Score: 1) |
|
| Mixed/dermal Melasma (51) | 6.9 ± 2.5 | 18 (35.3%) | 13 (25.4%) | 15 (29.4%) | 4 (7.8%) | 1 (1.9%) |
| Dermal Nevus (21) | 6.2 ± 1.4 | 8 (38%) | 5 (23.8%) | 5 (23.8%) | 2 (9.5%) | 1 (4.7%) |
| ADMH (11) | 5.9 ± 1.4 | 4 (36.3%) | 4 (36.3%) | 1 (9%) | 1 (9%) | 1 (9%) |
| Tattoo (39) | 7.9 ± 1.1 | 23 (58.9%) | 11 (28.3%) | 5 (12.8%) | 0 | 0 |